Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin vs Losartan for Prevention of Kidney Stones in Paraffin Disease
NCT07828002Phase 3Not yet recruiting
- Start
- Sep 2026
- Primary completion
- Mar 2029
- Countries
- 1
01
Overview
A Phase 3 trial of empagliflozin, losartan in nephrolithiasis, paraffinoma. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
empagliflozinlosartan
03
Conditions
nephrolithiasisparaffinoma
Beyond the preview
Go deeper on NCT07828002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07828002.